|
|
|
Volumn 29, Issue 2, 2009, Pages
|
|
Off-label use of bevacizumab in retinopathy of prematurity.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
VASCULOTROPIN A;
CLASSIFICATION;
DRUG ANTAGONISM;
EXTREMELY LOW BIRTH WEIGHT;
HUMAN;
INFANT;
INJECTION;
NEWBORN;
NOTE;
RETROLENTAL FIBROPLASIA;
TREATMENT OUTCOME;
VITREOUS BODY;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
HUMANS;
INFANT;
INFANT, EXTREMELY LOW BIRTH WEIGHT;
INFANT, NEWBORN;
INJECTIONS;
RETINOPATHY OF PREMATURITY;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VITREOUS BODY;
|
|
EID: 63249106425
PISSN: None
EISSN: 15392864
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
